Extendicare Inc.

WHO'M
ai
Digital Profiler. Simply click the AI button
CUSIP

30224T863
SEDOL

BF2HFL9
CIK

N/A

extendicare.com
LEI:
FIGI: BBG000DLD469
EXE

Extendicare Inc.
GICS: - · Sector: - · Sub-Sector: -
NAME
Extendicare Inc.
ISIN
CA30224T8639
TICKER
EXE
MIC
XTSE
REUTERS
EXE.TO
BLOOMBERG
EXE CN
EN 728x90
FOR INVESTORS
FOR TRADERS
Securities Trading Warrants

GlobeNewswire is an important news source that provides investors with company-related information. In particular, it deals with events that may be relevant to the listing of companies or tradable financial instruments. You can access the complete overview of all reports via this link.

Tue, 12.11.2024

MARKHAM, Ontario, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and nine months ended September 30, 2024, and the Company announced that it is exercising its option to redeem all of the outstanding $126.5 million principal amount of 2018-1 5.00% convertible unsecured subordinated debentures (TSX: EXE.DB.C) (the “2025 Debentures”).

Fri, 08.11.2024

MARKHAM, Ontario, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today announced that it has entered into a new senior secured credit facility for $275.0 million (the “Senior Secured Credit Facility”) with a syndicate of Canadian chartered banks, for a term of three years. The Senior Secured Credit Facility consists of a revolving credit facility for up to $145.0 million (the “Revolving Facility”), which replaces the Company’s former demand credit facilities of $112.3 million, and a delayed draw term loan facility in an amount up to $130.0 million (the “Delayed Draw Facility”). The Revolving Facility is available for working capital and general corporate purposes, including capital expenditures and acquisitions. The Delayed Draw Facility is available until April 30, 2025 to repay the Company’s outstanding $126.5 million of 5.00% convertible subordinated debentures due April 30, 2025 (the “2025 Debentures”). Extendicare may redeem the 2025 Debentures before their maturity date in April 2025.

Tue, 15.10.2024

MARKHAM, Ontario, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common Share”) for the month of October 2024, which is payable on November 15, 2024 to shareholders of record at the close of business on October 31, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).

Fri, 04.10.2024

MARKHAM, Ontario, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the third quarter of 2024 after market close on Tuesday, November 12, 2024. A conference call hosted by Michael Guerriere, President and Chief Executive Officer, and David Bacon, Senior Vice President and Chief Financial Officer, will be held on Wednesday, November 13, 2024, at 11:30 a.m. (ET) to discuss the results.

Mon, 16.09.2024

MARKHAM, Ontario, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common Share”) for the month of September 2024, which is payable on October 15, 2024 to shareholders of record at the close of business on September 30, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).

Mon, 12.08.2024

MARKHAM, Ontario, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and six months ended June 30, 2024.

Mon, 15.07.2024

MARKHAM, Ontario, July 15, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common Share”) for the month of July 2024, which is payable on August 15, 2024 to shareholders of record at the close of business on July 31, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).

Fri, 05.07.2024

MARKHAM, Ontario, July 05, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the second quarter of 2024 after market close on Monday, August 12, 2024. A conference call hosted by Michael Guerriere, President and Chief Executive Officer, and David Bacon, Senior Vice President and Chief Financial Officer, will be held on Tuesday, August 13, 2024, at 11:30 a.m. (ET) to discuss the results.

Wed, 26.06.2024

MARKHAM, Ontario, June 26, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that the Toronto Stock Exchange (the “TSX”) has approved the renewal of Extendicare’s normal course issuer bid (“NCIB”). Under the terms of the NCIB, the Company may purchase for cancellation up to 7,159,997 of its common shares (the “Common Shares”), representing 10% of its public float of issued and outstanding Common Shares. As at June 18, 2024, there were 83,466,978 Common Shares issued and outstanding and the public float was 71,599,973 Common Shares, calculated in accordance with the rules of the TSX.

Mon, 17.06.2024

MARKHAM, Ontario, June 17, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common Share”) for the month of June 2024, which is payable on July 15, 2024 to shareholders of record at the close of business on June 28, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).

We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Information on product placements